Brown Advisory Inc. Has $38.78 Million Position in LifeStance Health Group, Inc. (NASDAQ:LFST)

Brown Advisory Inc. reduced its position in LifeStance Health Group, Inc. (NASDAQ:LFST - Free Report) by 3.2% in the 1st quarter, according to its most recent filing with the SEC. The firm owned 5,822,615 shares of the company's stock after selling 192,227 shares during the period. Brown Advisory Inc. owned about 1.51% of LifeStance Health Group worth $38,779,000 at the end of the most recent reporting period.

Several other hedge funds and other institutional investors have also recently bought and sold shares of the company. LPL Financial LLC grew its stake in shares of LifeStance Health Group by 6.0% during the 4th quarter. LPL Financial LLC now owns 37,584 shares of the company's stock valued at $277,000 after buying an additional 2,127 shares during the period. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its position in LifeStance Health Group by 2.4% during the 4th quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 138,781 shares of the company's stock worth $1,023,000 after purchasing an additional 3,305 shares during the period. MetLife Investment Management LLC boosted its position in LifeStance Health Group by 6.8% during the 4th quarter. MetLife Investment Management LLC now owns 85,914 shares of the company's stock worth $633,000 after purchasing an additional 5,492 shares during the period. Legal & General Group Plc boosted its position in LifeStance Health Group by 4.6% during the 4th quarter. Legal & General Group Plc now owns 134,557 shares of the company's stock worth $992,000 after purchasing an additional 5,917 shares during the period. Finally, Price T Rowe Associates Inc. MD lifted its holdings in LifeStance Health Group by 15.6% in the 4th quarter. Price T Rowe Associates Inc. MD now owns 66,855 shares of the company's stock worth $493,000 after buying an additional 9,009 shares in the last quarter. 85.50% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have weighed in on LFST. KeyCorp began coverage on shares of LifeStance Health Group in a research report on Tuesday, April 8th. They issued an "overweight" rating and a $9.00 price objective for the company. UBS Group raised shares of LifeStance Health Group from a "neutral" rating to a "buy" rating and set a $8.50 price target for the company in a research report on Tuesday, May 27th. Finally, Canaccord Genuity Group began coverage on shares of LifeStance Health Group in a research report on Thursday, April 3rd. They set a "buy" rating and a $8.00 price target for the company. One analyst has rated the stock with a sell rating, four have assigned a buy rating and one has assigned a strong buy rating to the stock. According to data from MarketBeat, the stock has an average rating of "Moderate Buy" and an average target price of $8.50.

Insider Activity

In related news, insider Ujjwal Ramtekkar sold 16,000 shares of the company's stock in a transaction dated Thursday, June 5th. The shares were sold at an average price of $5.94, for a total value of $95,040.00. Following the completion of the sale, the insider owned 113,435 shares of the company's stock, valued at $673,803.90. This represents a 12.36% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Company insiders own 3.20% of the company's stock.

LifeStance Health Group Stock Up 1.6%

Shares of LifeStance Health Group stock traded up $0.08 during trading on Thursday, reaching $4.83. The company had a trading volume of 841,039 shares, compared to its average volume of 1,674,394. The company has a market cap of $1.88 billion, a price-to-earnings ratio of -48.24 and a beta of 1.16. The firm's fifty day moving average is $5.53 and its 200-day moving average is $6.72. The company has a debt-to-equity ratio of 0.19, a quick ratio of 1.47 and a current ratio of 1.47. LifeStance Health Group, Inc. has a fifty-two week low of $4.61 and a fifty-two week high of $8.61.

LifeStance Health Group Profile

LifeStance Health Group, Inc, through its subsidiaries, provides outpatient mental health services to children, adolescents, adults, and geriatrics in the United States. The company offers patients a suite of mental health services, including psychiatric evaluations and treatment, psychological, and neuropsychological testing, as well as individual, family, and group therapy.